UnitedHealth Group Inc (UNH) Expected to Announce Quarterly Sales of $54.85 Billion
Equities research analysts predict that UnitedHealth Group Inc (NYSE:UNH) will report sales of $54.85 billion for the current quarter, Zacks reports. Six analysts have made estimates for UnitedHealth Group’s earnings, with the lowest sales estimate coming in at $54.15 billion and the highest estimate coming in at $55.38 billion. UnitedHealth Group posted sales of $48.72 billion during the same quarter last year, which suggests a positive year-over-year growth rate of 12.6%. The company is expected to announce its next quarterly earnings results on Tuesday, April 17th.
According to Zacks, analysts expect that UnitedHealth Group will report full year sales of $54.85 billion for the current year, with estimates ranging from $223.50 billion to $225.72 billion. For the next fiscal year, analysts anticipate that the company will post sales of $242.70 billion per share, with estimates ranging from $240.11 billion to $245.44 billion. Zacks Investment Research’s sales averages are an average based on a survey of sell-side analysts that follow UnitedHealth Group.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.50 by $0.09. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The firm had revenue of $52.06 billion during the quarter, compared to the consensus estimate of $51.57 billion. During the same period in the previous year, the firm posted $2.11 EPS. The company’s quarterly revenue was up 9.5% compared to the same quarter last year.
In other news, CEO Larry C. Renfro sold 22,598 shares of the company’s stock in a transaction on Friday, December 15th. The stock was sold at an average price of $221.75, for a total transaction of $5,011,106.50. Following the completion of the sale, the chief executive officer now directly owns 195,314 shares in the company, valued at approximately $43,310,879.50. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Michele J. Hooper sold 5,000 shares of the company’s stock in a transaction on Monday, December 4th. The stock was sold at an average price of $222.20, for a total value of $1,111,000.00. Following the sale, the director now owns 36,989 shares of the company’s stock, valued at $8,218,955.80. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 33,655 shares of company stock valued at $7,469,083. Insiders own 0.89% of the company’s stock.
Several hedge funds have recently added to or reduced their stakes in UNH. Iberiabank Corp boosted its position in UnitedHealth Group by 3.0% during the 2nd quarter. Iberiabank Corp now owns 4,311 shares of the healthcare conglomerate’s stock worth $799,000 after purchasing an additional 127 shares during the period. Private Trust Co. NA boosted its position in UnitedHealth Group by 10.1% during the 2nd quarter. Private Trust Co. NA now owns 8,150 shares of the healthcare conglomerate’s stock worth $1,511,000 after purchasing an additional 748 shares during the period. Covenant Asset Management LLC boosted its position in UnitedHealth Group by 2.7% during the 2nd quarter. Covenant Asset Management LLC now owns 7,185 shares of the healthcare conglomerate’s stock worth $1,332,000 after purchasing an additional 190 shares during the period. ETF Portfolio Partners Inc. purchased a new stake in UnitedHealth Group during the 2nd quarter worth $206,000. Finally, Central Bank & Trust Co. boosted its position in UnitedHealth Group by 0.8% during the 2nd quarter. Central Bank & Trust Co. now owns 17,992 shares of the healthcare conglomerate’s stock worth $3,336,000 after purchasing an additional 134 shares during the period. Institutional investors and hedge funds own 86.09% of the company’s stock.
Shares of UnitedHealth Group (UNH) traded up $0.19 during trading on Thursday, hitting $243.35. The company had a trading volume of 4,289,381 shares, compared to its average volume of 3,050,000. The company has a debt-to-equity ratio of 0.58, a current ratio of 0.73 and a quick ratio of 0.70. UnitedHealth Group has a 1 year low of $156.49 and a 1 year high of $244.35. The firm has a market cap of $235,290.00, a P/E ratio of 22.72, a P/E/G ratio of 1.42 and a beta of 0.66.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.